Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)Jean-Pascal Machiels, Lisa Licitra, Loris De Cecco et al.|Annals of Oncology|2018Cited by 43
Activity of afatinib administered in a window pre-operative study in squamous cell carcinoma of the head and neck (SCCHN) : EORTC-90111.Jean‐Pascal Machiels, Lisa Licitra, Jessica Menis et al.|Journal of Clinical Oncology|2016Cited by 4
Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111)Simon P. Beyaert, Sandra Schmitz, Axelle Loriot et al.|Clinical Cancer Research|2023Cited by 4
Supplementary Data - "Tables 1" from Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111)Simon P. Beyaert, Sandra Schmitz, Axelle Loriot et al.|Unknown|2023Cited by 0
Tables 2 from Tumor microenvironment modifications induced by afatinib in squamous cell carcinoma of the head and neck - a window-of-opportunity study (EORTC90111-24111)Simon P. Beyaert, Sandra Schmitz, Axelle Loriot et al.|Unknown|2024Cited by 0